Redefining Innovation in Rare Disease Drug Development
Join 1776, Horizon Therapeutics and partners for a panel discussion and reception about the current rare disease drug development landscape.
About this Event
Join 1776, Horizon Therapeutics and partners for a panel discussion and reception about innovative approaches to addressing the challenges of research and drug development in rare diseases. With 30 million patients living with a rare disease in the U.S., the panel will also explore how stakeholders in the rare disease community may work together to close the innovation gap and address unmet medical needs for patients.
Schedule of Events
5:30 p.m. Check In
5:30 p.m.- 6 p.m. Happy Hour & Networking
6 p.m.-7:15 p.m. Moderated Panel and Q&A
7:15 p.m. - 8 p.m. Networking
8 p.m. Event Conclusion
Moderator: Carter McClure – Managing Director, Pennovation Center
Panelist: Jennifer Farmer, MS, CGC – Executive Director, Friedreich’s Ataxia Research Alliance (FARA)
Panelist: Stephanie Fischer
- Member, Pennsylvania Rare Disease Advisory Council
- Executive Committee Member, Rare Advocacy Movement
Panelist: Saba Sile, M.D. – Executive Director, Clinical Development, Horizon Therapeutics
1776 transforms markets by curating communities of entrepreneurs and entreprises in flexible work environments. Our members gain access to a dynamic network and focused programming to provide the knowledge adn resources necessary to spur innovation and solve complex challenges. With 10 campuses across 5 different states, we are the nation's largest network of incubators. For more information, please visit www.1776.vc and follow @1776 on Twitter and @1776vc on Instagram.
About Horizon Therapeutics
Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.